NCT05257694View on ClinicalTrials.gov

Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning

RecruitingOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hepatocellular CarcinomaContrast-enhanced UltrasoundPrognosisSurgeryAblation
Interventions
PROCEDURE

Surgery

hepatectomy

PROCEDURE

Ablation (Microwave ablation or Radiofrequency ablation)

image-guided ablation

Trial Locations (1)

100853

RECRUITING

Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Ping Liang

OTHER